AIM IMMUNOTECH INC. Defined Contribution Plan, Cost
AIM IMMUNOTECH INC. (AIM) reported Defined Contribution Plan, Cost of $170.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2015-03-19
- AIM IMMUNOTECH INC. defined contribution plan, cost for fiscal 2014 was $170.00K, a 0.58% decline from fiscal 2013.
- AIM IMMUNOTECH INC. defined contribution plan, cost for fiscal 2013 was $171.00K, a 23.91% increase from fiscal 2012.
- AIM IMMUNOTECH INC. defined contribution plan, cost for fiscal 2012 was $138.00K, a 6.76% decline from fiscal 2011.
- AIM IMMUNOTECH INC. defined contribution plan, cost for fiscal 2011 was $148.00K, a 21.31% increase from fiscal 2010.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2014-12-31 | $170.00K 10-K · filed 2015-03-19 |
| 2013-12-31 | $171.00K 10-K · filed 2015-03-19 |
| 2012-12-31 | $138.00K 10-K · filed 2015-03-19 |
| 2011-12-31 | $148.00K 10-K · filed 2014-03-14 |
| 2010-12-31 | $122.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |